• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Glenn Stettin Outlines the Importance of Transparency for PBMs

Video

Being transparent is important for pharmacy benefit managers in order to know what the criteria are for coverage, said Glenn D. Stettin, MD.

Being transparent is important for pharmacy benefit managers in order to know what the criteria are for coverage, said Glenn D. Stettin, MD.

Transcript (modified)

How can pharmacy benefit managers be more transparent and how does it benefit them to do so?

I don’t know that I can speak for the industry, but I can say that at Express Scripts it is important for us, for physicians, to know what the criteria are for coverage, specifically for the plans where we manage the prior authorization process. So we make that information available that physicians can find it, and then the other areas in what drugs actually cost. One of our recent introductions is the pricing tool and mobile application for our patients, where they can actually put in the name of a drug and look it up to find what that medication would cost at the pharmacy and at different pharmacies — because sometimes different pharmacies have different pricing. Or it doesn’t help yet and we need to do more are for drugs that are billed under the medical benefit as opposed to the pharmacy benefit. And I think that we have some good plans in place to make that kind of pricing transparency available, as well.

Related Videos
Dr Amrita Basu
Justin Drake, PhD
Joanna Rhodes, MD, MSCE, director of the lymphoma program at the Rutgers Cancer Institute and the assistant head of lymphoma at Robert Wood Johnson Medical School
Ira Zackon, MD, senior medical director, Ontada
Shayla Bergmann, MD, a clinical professor in pediatric hematology at the Medical University of South Carolina
Erika Hamilton, MD
Ivo Carre, PhD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.